Compounds > cgp 39551
Page last updated: 2024-09-02

cgp 39551 and orphenadrine

cgp 39551 has been researched along with orphenadrine in 1 studies

Compound Research Comparison

Studies
(cgp 39551)		Trials
(cgp 39551)		Recent Studies (post-2010)
(cgp 39551)		Studies
(orphenadrine)		Trials
(orphenadrine)		Recent Studies (post-2010) (orphenadrine)
75045416159

Protein Interaction Comparison

ProteinTaxonomycgp 39551 (IC50)orphenadrine (IC50)
Solute carrier family 22 member 2Homo sapiens (human)2.5
5-hydroxytryptamine receptor 4Cavia porcellus (domestic guinea pig)0.534
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)2.666
Muscarinic acetylcholine receptor M2Homo sapiens (human)0.376
Muscarinic acetylcholine receptor M4Homo sapiens (human)0.125
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.028
Alpha-2A adrenergic receptorHomo sapiens (human)2.156
Cytochrome P450 2D6Homo sapiens (human)0.4
Muscarinic acetylcholine receptor M1Homo sapiens (human)0.148
Alpha-2B adrenergic receptorHomo sapiens (human)1.895
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.175
Sodium-dependent noradrenaline transporter Homo sapiens (human)2.666
Histamine H2 receptorHomo sapiens (human)6.961
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.436
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.534
Sodium-dependent serotonin transporterHomo sapiens (human)0.458
Histamine H1 receptorHomo sapiens (human)1.241
5-hydroxytryptamine receptor 2BHomo sapiens (human)3.391
5-hydroxytryptamine receptor 6Homo sapiens (human)1.121
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.8511

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Czuczwar, M; Kiś, J; Nieoczym, D; Rejdak, K; Turski, WA; Wlaź, P1

Other Studies

1 other study(ies) available for cgp 39551 and orphenadrine

ArticleYear
Orphenadrine-induced convulsive status epilepticus in rats responds to the NMDA antagonist dizocilpine.
    Pharmacological reports : PR, 2014, Volume: 66, Issue:3

    Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Dizocilpine Maleate; Electroencephalography; Hippocampus; Male; N-Methylaspartate; Orphenadrine; Rats; Rats, Wistar; Seizures; Status Epilepticus

2014